An in-depth look to APEX BIOTECHNOLOGY CORP operating, investing, and financing activities

1733 free cash flow for Q3 24 is 45.82 M TWD. For 2023, 1733 free cash flow was 244.27 M TWD and operating cash flow was 266.18 M TWD.